This study demonstrates the potential of lactobacillus isolates to combat bowel infections, indicating possible uses in novel probiotic therapies.
This study highlights the potential of Lactobacillus isolates (from curd & kefir) as probiotics against bowel infections. The isolates showed optimal growth at 0.5% salt concentration and pH 5, with varying levels of tolerance to different salt concentrations and pH levels. Notably, S12 and S33 exhibited high colony counts at 0.5% salt concentration, indicating their potential as salt-tolerant isolates. Lactobacillus species can strengthen the gut barrier, produce antimicrobial substances, and modulate the immune system, contributing to their potential health benefits. These findings suggest that these isolates could be used to develop novel probiotics or antimicrobial therapies to prevent or treat bowel infections, and further research is needed to explore their mechanisms of action and potential applications.
No takes yet. Share an insight, caveat, or question.
Peter et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: